Talkspace Launches New Mental Health Portal for Employers

Talkspace Launches New Mental Health Portal for Employers

Virtual behavioral health provider Talkspace unveiled a new product Thursday that provides employers with access to a library of mental health resources that they can share with employees.
New York City-based Talkspace serves employers, payers and consumers, and provides self-guided mental health programs, therapy and psychiatry. Its new product, Talkspace Engage, aims to help employers promote their mental health benefits to their employees, a challenge that many companies struggle with, said Erin Boyd, chief growth officer of enterprise at Talkspace. “One resounding common theme that we heard among [employers] was that, ‘I don’t know how to get people to use these benefits…

Continue Reading
Caraway, Ash Wellness Launch Partnership to Combat Rise in STIs on College Campuses

Caraway, Ash Wellness Launch Partnership to Combat Rise in STIs on College Campuses

In order to catch the attention of reporters, companies often look for creative news hooks to tie their announcements to. Two companies have decided to use Valentine’s Day to forward their message of sexually transmitted infection prevention. How romantic!
Digital health startup Caraway Health is teaming up with at-home testing company Ash Wellness to provide STI kits for those aged 18 to 27, the companies announced Tuesday. New York City-based Caraway provides mental, physical and reproductive health services for Gen-Z populations, with a particular focus on women and people assigned female at birth. It offers an app that enables users to access its…

Continue Reading
New York approves AI-driven breast cancer diagnostic

New York approves AI-driven breast cancer diagnostic

With Clinical Laboratory Evaluation Program assay validation, the company’s Clinical Laboratory Improvement Amendments-certified lab can begin testing patient samples.WHY IT MATTERS
Along with New York State Department of Health clinical and analytical validation of this use of array morphology, the results of the PDxBr test were reproducible.
“Consistent with our mission of improving healthcare, PDxBr has shown to be an effective prognostic tool to further improve risk stratification over current histopathology methods,” said Wayne Brinster, CEO of PreciseDx, in an announcement.
The company says the AI technology has now proven its ability to enhance invasive breast cancer pathology interpretation with objective, quantifiable and accurate…

Continue Reading